{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:58:51Z","timestamp":1791377931815,"version":"4.3.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61266-3","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:25:42Z","timestamp":1783423542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum REG3\u03b1 as a biomarker for clinical and endoscopic activity in ulcerative colitis"],"prefix":"10.1038","volume":"16","author":[{"given":"Seung-Jun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-In","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeungCheon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Moon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Seon","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"61266_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner, D. et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 160, 1570\u20131583. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031 (2021).","journal-title":"Gastroenterology"},{"key":"61266_CR2","doi-asserted-by":"publisher","first-page":"S614","DOI":"10.14309\/00000434-201210001-01530","volume":"107","author":"O Lin","year":"2012","unstructured":"Lin, O. & Kozarek, R. Compliance of Inflammatory Bowel Disease Patients with Guideline Recommendations for Laboratory Monitoring, Colonoscopic Surveillance and DEXA Scanning: 1530. Official J. Am. Coll. Gastroenterol. | ACG. 107, S614 (2012).","journal-title":"Official J. Am. Coll. Gastroenterol. | ACG"},{"key":"61266_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1177\/2050640616686517","volume":"5","author":"C Marechal","year":"2017","unstructured":"Marechal, C. et al. Compliance with the faecal calprotectin test in patients with inflammatory bowel disease. United Eur. Gastroenterol. J. 5, 702\u2013707. https:\/\/doi.org\/10.1177\/2050640616686517 (2017).","journal-title":"United Eur. Gastroenterol. J."},{"key":"61266_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/00365521.2014.987809","volume":"50","author":"T Sipponen","year":"2015","unstructured":"Sipponen, T. & Kolho, K. L. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scand. J. Gastroenterol. 50, 74\u201380. https:\/\/doi.org\/10.3109\/00365521.2014.987809 (2015).","journal-title":"Scand. J. Gastroenterol."},{"key":"61266_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ajg.2015.6","volume":"110","author":"SB Menees","year":"2015","unstructured":"Menees, S. B., Powell, C., Kurlander, J., Goel, A. & Chey, W. D. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am. J. Gastroenterol. 110, 444\u2013454. https:\/\/doi.org\/10.1038\/ajg.2015.6 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"61266_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/hep.24087","volume":"53","author":"N Moniaux","year":"2011","unstructured":"Moniaux, N. et al. Human hepatocarcinoma-intestine-pancreas\/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured livers. Hepatology 53, 618\u2013627. https:\/\/doi.org\/10.1002\/hep.24087 (2011).","journal-title":"Hepatology"},{"key":"61266_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389\u2013395. https:\/\/doi.org\/10.1038\/415389a (2002).","journal-title":"Nature"},{"key":"61266_CR8","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/ibd.22887","volume":"18","author":"Y Lv","year":"2012","unstructured":"Lv, Y. et al. Adenovirus-mediated hepatocarcinoma-intestine-pancreas\/pancreatitis-associated protein suppresses dextran sulfate sodium-induced acute ulcerative colitis in rats. Inflamm. Bowel Dis. 18, 1950\u20131960. https:\/\/doi.org\/10.1002\/ibd.22887 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"61266_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.canlet.2015.03.014","volume":"362","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2\/STAT3 positive feedback loop. Cancer Lett. 362, 45\u201360. https:\/\/doi.org\/10.1016\/j.canlet.2015.03.014 (2015).","journal-title":"Cancer Lett."},{"key":"61266_CR10","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.4049\/jimmunol.176.6.3774","volume":"176","author":"E Folch-Puy","year":"2006","unstructured":"Folch-Puy, E., Granell, S., Dagorn, J. C., Iovanna, J. L. & Closa, D. Pancreatitis-associated protein I suppresses NF-kappa B activation through a JAK\/STAT-mediated mechanism in epithelial cells. J. Immunol. 176, 3774\u20133779. https:\/\/doi.org\/10.4049\/jimmunol.176.6.3774 (2006).","journal-title":"J. Immunol."},{"key":"61266_CR11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.bbmt.2016.04.022","volume":"22","author":"AM Ali","year":"2016","unstructured":"Ali, A. M., DiPersio, J. F. & Schroeder, M. A. The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review. Biol. Blood Marrow Transpl. 22, 1552\u20131564. https:\/\/doi.org\/10.1016\/j.bbmt.2016.04.022 (2016).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"61266_CR12","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2011-10-387357","volume":"119","author":"AC Harris","year":"2012","unstructured":"Harris, A. C. et al. Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood 119, 2960\u20132963. https:\/\/doi.org\/10.1182\/blood-2011-10-387357 (2012).","journal-title":"Blood"},{"key":"61266_CR13","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1182\/blood-2012-01-403063","volume":"119","author":"JE Levine","year":"2012","unstructured":"Levine, J. E. et al. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. Blood 119, 3854\u20133860. https:\/\/doi.org\/10.1182\/blood-2012-01-403063 (2012).","journal-title":"Blood"},{"key":"61266_CR14","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1053\/j.gastro.2009.08.069","volume":"137","author":"WJ Sandborn","year":"2009","unstructured":"Sandborn, W. J. et al. Delayed-release oral mesalamine 4.8\u00a0g\/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis. Gastroenterology 137, 1934\u20131943. https:\/\/doi.org\/10.1053\/j.gastro.2009.08.069 (2009). e1931-1933.","journal-title":"Gastroenterology"},{"key":"61266_CR15","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/jgh.16895","volume":"40","author":"K Cameron","year":"2025","unstructured":"Cameron, K. et al. Review Article: Albumin and Its Role in Inflammatory Bowel Disease: The Old, the New, and the Future. J. Gastroenterol. Hepatol. 40, 808\u2013820. https:\/\/doi.org\/10.1111\/jgh.16895 (2025).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"61266_CR16","doi-asserted-by":"publisher","unstructured":"Darnaud, M. et al. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis. Gastroenterology. 154, 1009\u20131023 e1014, (2018). https:\/\/doi.org\/10.1053\/j.gastro.2017.11.003","DOI":"10.1053\/j.gastro.2017.11.003"},{"key":"61266_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/apt.12920","volume":"40","author":"I Marafini","year":"2014","unstructured":"Marafini, I. et al. Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies. Aliment. Pharmacol. Ther. 40, 974\u2013981. https:\/\/doi.org\/10.1111\/apt.12920 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"61266_CR18","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/ajg.2016.342","volume":"111","author":"R Kalla","year":"2016","unstructured":"Kalla, R. et al. Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases. Official J. Am. Coll. Gastroenterol. | ACG. 111, 1796\u20131805. https:\/\/doi.org\/10.1038\/ajg.2016.342 (2016).","journal-title":"Official J. Am. Coll. Gastroenterol. | ACG"},{"key":"61266_CR19","doi-asserted-by":"publisher","first-page":"A244","DOI":"10.1136\/gutjnl-2013-304907.569","volume":"62","author":"NC Hare","year":"2013","unstructured":"Hare, N. C. et al. PTH-082\u2005Serum Calprotectin: A Novel Biomarker to Predict Outcome in Acute Severe Ulcerative Colitis?. Gut 62, A244\u2013A245. https:\/\/doi.org\/10.1136\/gutjnl-2013-304907.569 (2013).","journal-title":"Gut"},{"key":"61266_CR20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1080\/00365521.2019.1665097","volume":"54","author":"M Malham","year":"2019","unstructured":"Malham, M. et al. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis. Scand. J. Gastroenterol. 54, 1214\u20131219. https:\/\/doi.org\/10.1080\/00365521.2019.1665097 (2019).","journal-title":"Scand. J. Gastroenterol."},{"key":"61266_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000545722","volume":"10","author":"S Honap","year":"2025","unstructured":"Honap, S. et al. Plasma Concentration of Calprotectin, but Not Serum Concentration, Is a Predictive Biomarker for Clinical Remission in Ulcerative Colitis. Inflamm. Intest Dis. 10, 104\u2013114. https:\/\/doi.org\/10.1159\/000545722 (2025).","journal-title":"Inflamm. Intest Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61266-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:03:11Z","timestamp":1791374591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61266-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61266-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8400093\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31203"}}